| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.085 | 0.08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.06 | 0.3 |